{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T14:45:38Z","timestamp":1745333138319,"version":"3.40.3"},"publisher-location":"Dordrecht","reference-count":165,"publisher":"Springer Netherlands","isbn-type":[{"type":"print","value":"9789401787536"},{"type":"electronic","value":"9789401787543"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-94-017-8754-3_13","type":"book-chapter","created":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T09:35:19Z","timestamp":1398677719000},"page":"263-290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cancer Stem Cells in Gynecologic Cancer"],"prefix":"10.1007","author":[{"given":"Juan Carlos Mell\u00eddez","family":"Barroso","sequence":"first","affiliation":[]},{"given":"Maria C.","family":"Santos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,3,21]]},"reference":[{"issue":"3","key":"13_CR1","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s12015-011-9344-5","volume":"8","author":"C Aguilar-Gallardo","year":"2012","unstructured":"Aguilar-Gallardo C, Rutledge EC, Martinez-Arroyo AM, Hidalgo JJ, Domingo S, Simon C (2012) Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches. Stem Cell Rev 8(3):994\u20131010. doi:10.1007\/s12015-011-9344-5","journal-title":"Stem Cell Rev"},{"issue":"1","key":"13_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/jcb.24317","volume":"114","author":"N Ahmed","year":"2013","unstructured":"Ahmed N, Abubaker K, Findlay J, Quinn M (2013) Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance. J Cell Biochem 114(1):21\u201334. doi:10.1002\/jcb.24317","journal-title":"J Cell Biochem"},{"issue":"7","key":"13_CR3","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100(7):3983\u20133988. doi:10.1073\/pnas.0530291100","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"13_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ctrv.2012.03.003","volume":"38","author":"MR Alison","year":"2012","unstructured":"Alison MR, Lin WR, Lim SM, Nicholson LJ (2012) Cancer stem cells: in the line of fire. Cancer Treat Rev 38(6):589\u2013598. doi:10.1016\/j.ctrv.2012.03.003","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"13_CR5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/cc.8.1.7533","volume":"8","author":"AB Alvero","year":"2009","unstructured":"Alvero AB, Chen R, Fu HH, Montagna M, Schwartz PE, Rutherford T, Silasi DA, Steffensen KD, Waldstrom M, Visintin I, Mor G (2009) Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle 8(1):158\u2013166","journal-title":"Cell Cycle"},{"issue":"8","key":"13_CR6","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1158\/1535-7163.MCT-11-0023","volume":"10","author":"AB Alvero","year":"2011","unstructured":"Alvero AB, Montagna MK, Holmberg JC, Craveiro V, Brown D, Mor G (2011) Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells. Mol Cancer Ther 10(8):1385\u20131393. doi:10.1158\/1535-7163.MCT-11-0023","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"13_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1757-2215-2-16","volume":"2","author":"NS Anderson","year":"2009","unstructured":"Anderson NS, Turner L, Livingston S, Chen R, Nicosia SV, Kruk PA (2009) Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation. J Ovarian Res 2(1):16. doi:10.1186\/1757-2215-2-16","journal-title":"J Ovarian Res"},{"issue":"2","key":"13_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1210\/er.22.2.255","volume":"22","author":"N Auersperg","year":"2001","unstructured":"Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22(2):255\u2013288. doi:10.1210\/er.22.2.255","journal-title":"Endocr Rev"},{"issue":"3","key":"13_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2217\/epi.10.19","volume":"2","author":"C Balch","year":"2010","unstructured":"Balch C, Matei DE, Huang TH, Nephew KP (2010) Role of epigenomics in ovarian and endometrial cancers. Epigenomics 2(3):419\u2013447. doi:10.2217\/epi.10.19","journal-title":"Epigenomics"},{"issue":"1","key":"13_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1757-2215-5-8","volume":"5","author":"J Baley","year":"2012","unstructured":"Baley J, Li J (2012) MicroRNAs and ovarian function. J Ovarian Res 5(1):8. doi:10.1186\/1757-2215-5-8","journal-title":"J Ovarian Res"},{"issue":"1","key":"13_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1530\/REP-09-0389","volume":"140","author":"SA Bapat","year":"2010","unstructured":"Bapat SA (2010) Human ovarian cancer stem cells. Reproduction 140(1):33\u201341. doi:10.1530\/REP-09-0389","journal-title":"Reproduction"},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/978-94-007-4525-4_18","volume":"61","author":"SA Bapat","year":"2012","unstructured":"Bapat SA (2012) Epigenetic regulation of cancer stem cell gene expression. Subcell Biochem 61:419\u2013434. doi:10.1007\/978-94-007-4525-4_18","journal-title":"Subcell Biochem"},{"issue":"8","key":"13_CR13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.4161\/epi.5.8.13014","volume":"5","author":"SA Bapat","year":"2010","unstructured":"Bapat SA, Jin V, Berry N, Balch C, Sharma N, Kurrey N, Zhang S, Fang F, Lan X, Li M, Kennedy B, Bigsby RM, Huang TH, Nephew KP (2010) Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells. Epigenetics 5(8):716\u2013729","journal-title":"Epigenetics"},{"issue":"8","key":"13_CR14","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1158\/0008-5472.CAN-04-3931","volume":"65","author":"SA Bapat","year":"2005","unstructured":"Bapat SA, Mali AM, Koppikar CB, Kurrey NK (2005) Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 65(8):3025\u20133029. doi:10.1158\/0008-5472.CAN-04-3931","journal-title":"Cancer Res"},{"issue":"6","key":"13_CR15","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1053\/j.gastro.2007.10.029","volume":"133","author":"N Barker","year":"2007","unstructured":"Barker N, Clevers H (2007) Tracking down the stem cells of the intestine: strategies to identify adult stem cells. Gastroenterology 133(6):1755\u20131760. doi:10.1053\/j.gastro.2007.10.029","journal-title":"Gastroenterology"},{"issue":"2","key":"13_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00432-012-1334-8","volume":"139","author":"D Bauerschlag","year":"2013","unstructured":"Bauerschlag D, Brautigam K, Moll R, Sehouli J, Mustea A, Salehin D, Krajewska M, Reed JC, Maass N, Hampton GM, Meinhold-Heerlein I (2013) Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovary. J Cancer Res Clin Oncol 139(2):347\u2013355. doi:10.1007\/s00432-012-1334-8","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"13_CR17","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/IGC.0b013e3181a8331f","volume":"19","author":"S Bellone","year":"2009","unstructured":"Bellone S, Siegel ER, Cocco E, Cargnelutti M, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD (2009) Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent\/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy. Int J Gynecol Cancer 19(5):860\u2013866. doi:10.1111\/IGC.0b013e3181a8331f","journal-title":"Int J Gynecol Cancer"},{"issue":"2 Pt 2","key":"13_CR18","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/S0090-8258(03)00342-1","volume":"90","author":"ML Berman","year":"2003","unstructured":"Berman ML (2003) Future directions in the surgical management of ovarian cancer. Gynecol Oncol 90(2 Pt 2):S33\u2013S39. doi:10.1016\/S0090-8258(03)00342-1","journal-title":"Gynecol Oncol"},{"key":"13_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1757-2215-1-8","volume":"1","author":"NB Berry","year":"2008","unstructured":"Berry NB, Bapat SA (2008) Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype. J Ovarian Res 1:8. doi:10.1186\/1757-2215-1-8","journal-title":"J Ovarian Res"},{"issue":"1","key":"13_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2012.02.002","volume":"322","author":"D Burgos-Ojeda","year":"2012","unstructured":"Burgos-Ojeda D, Rueda BR, Buckanovich RJ (2012) Ovarian cancer stem cell markers: prognostic and therapeutic implications. Cancer Lett 322(1):1\u20137. doi:10.1016\/j.canlet.2012.02.002","journal-title":"Cancer Lett"},{"issue":"1","key":"13_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1261\/rna.035295.112","volume":"19","author":"N Cai","year":"2013","unstructured":"Cai N, Wang YD, Zheng PS (2013) The microRNA-302-367 cluster suppresses the proliferation of cervical carcinoma cells through the novel target AKT1. RNA 19(1):85\u201395. doi:10.1261\/rna.035295.112","journal-title":"RNA"},{"issue":"4","key":"13_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/PGP.0b013e3182102754","volume":"30","author":"I Cervello","year":"2011","unstructured":"Cervello I, Mirantes C, Santamaria X, Dolcet X, Matias-Guiu X, Simon C (2011) Stem cells in human endometrium and endometrial carcinoma. Int J Gynecol Pathol 30(4):317\u2013327. doi:10.1097\/PGP.0b013e3182102754","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"13_CR23","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1095\/biolreprod.103.024109","volume":"70","author":"RW Chan","year":"2004","unstructured":"Chan RW, Schwab KE, Gargett CE (2004) Clonogenicity of human endometrial epithelial and stromal cells. Biol Reprod 70(6):1738\u20131750. doi:10.1095\/biolreprod.103.024109","journal-title":"Biol Reprod"},{"issue":"6","key":"13_CR24","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/modpathol.2009.35","volume":"22","author":"B Chang","year":"2009","unstructured":"Chang B, Liu G, Xue F, Rosen DG, Xiao L, Wang X, Liu J (2009) ALDH1 expression correlates with favorable prognosis in ovarian cancers. Mod Pathol 22(6):817\u2013823. doi:10.1038\/modpathol.2009.35","journal-title":"Mod Pathol"},{"issue":"12","key":"13_CR25","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.molmed.2010.08.001","volume":"16","author":"ZG Chen","year":"2010","unstructured":"Chen ZG (2010) Small-molecule delivery by nanoparticles for anticancer therapy. Trends Mol Med 16(12):594\u2013602. doi:10.1016\/j.molmed.2010.08.001","journal-title":"Trends Mol Med"},{"issue":"8","key":"13_CR26","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00432-010-0772-4","volume":"136","author":"W Cheng","year":"2010","unstructured":"Cheng W, Jiang Y, Liu C, Shen O, Tang W, Wang X (2010) Identification of aberrant promoter hypomethylation of HOXA10 in ovarian cancer. J Cancer Res Clin Oncol 136(8):1221\u20131227. doi:10.1007\/s00432-010-0772-4","journal-title":"J Cancer Res Clin Oncol"},{"issue":"19","key":"13_CR27","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","volume":"66","author":"MF Clarke","year":"2006","unstructured":"Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM (2006) Cancer stem cells\u2013perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66(19):9339\u20139344. doi:10.1158\/0008-5472.CAN-06-3126","journal-title":"Cancer Res"},{"issue":"3","key":"13_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.2304","volume":"17","author":"H Clevers","year":"2011","unstructured":"Clevers H (2011) The cancer stem cell: premises, promises and challenges. Nat Med 17(3):313\u2013319. doi:10.1038\/nm.2304","journal-title":"Nat Med"},{"issue":"12","key":"13_CR29","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1002\/stem.236","volume":"27","author":"MD Curley","year":"2009","unstructured":"Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden DT, Rueda BR, Foster R (2009) CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells 27(12):2875\u20132883. doi:10.1002\/stem.236","journal-title":"Stem Cells"},{"issue":"1","key":"13_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00280-010-1462-2","volume":"68","author":"I De Stefano","year":"2011","unstructured":"De Stefano I, Battaglia A, Zannoni GF, Prisco MG, Fattorossi A, Travaglia D, Baroni S, Renier D, Scambia G, Ferlini C, Gallo D (2011) Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts. Cancer Chemother Pharmacol 68(1):107\u2013116. doi:10.1007\/s00280-010-1462-2","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"13_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1586\/era.11.194","volume":"12","author":"TH Dellinger","year":"2012","unstructured":"Dellinger TH, Planutis K, Tewari KS, Holcombe RF (2012) Role of canonical Wnt signaling in endometrial carcinogenesis. Expert Rev Anticancer Ther 12(1):51\u201362. doi:10.1586\/era.11.194","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"13_CR32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4161\/mabs.1.1.7347","volume":"1","author":"MP Deonarain","year":"2009","unstructured":"Deonarain MP, Kousparou CA, Epenetos AA (2009) Antibodies targeting cancer stem cells: a new paradigm in immunotherapy? MAbs 1(1):12\u201325","journal-title":"MAbs"},{"issue":"9","key":"13_CR33","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/ng1855","volume":"38","author":"M Dews","year":"2006","unstructured":"Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, Thomas-Tikhonenko A (2006) Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38(9):1060\u20131065. doi:10.1038\/ng1855","journal-title":"Nat Genet"},{"key":"13_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1476-4598-10-99","volume":"10","author":"P Dong","year":"2011","unstructured":"Dong P, Kaneuchi M, Watari H, Hamada J, Sudo S, Ju J, Sakuragi N (2011) MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer 10:99. doi:10.1186\/1476-4598-10-99","journal-title":"Mol Cancer"},{"issue":"3","key":"13_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jconrel.2007.05.005","volume":"122","author":"VS Donnenberg","year":"2007","unstructured":"Donnenberg VS, Landreneau RJ, Donnenberg AD (2007) Tumorigenic stem and progenitor cells: implications for the therapeutic index of anti-cancer agents. J Control Release 122(3):385\u2013391. doi:10.1016\/j.jconrel.2007.05.005","journal-title":"J Control Release"},{"issue":"1","key":"13_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12015-007-0004-8","volume":"3","author":"O Dreesen","year":"2007","unstructured":"Dreesen O, Brivanlou AH (2007) Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev 3(1):7\u201317. doi:10.1007\/s12015-007-0004-8","journal-title":"Stem Cell Rev"},{"issue":"1","key":"13_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/cyto.a.22206","volume":"83","author":"A Fabian","year":"2013","unstructured":"Fabian A, Vereb G, Szollosi J (2013) The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy. Cytometry A 83(1):62\u201371. doi:10.1002\/cyto.a.22206","journal-title":"Cytometry A"},{"issue":"20","key":"13_CR38","doi-asserted-by":"publisher","first-page":"9328","DOI":"10.1158\/0008-5472.CAN-05-1343","volume":"65","author":"D Fang","year":"2005","unstructured":"Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65(20):9328\u20139337. doi:10.1158\/0008-5472.CAN-05-1343","journal-title":"Cancer Res"},{"key":"13_CR39","unstructured":"Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D (2010) GLOBOCAN 2008 v1.2: cancer incidence and mortality worldwide: IARC CancerBase No. 10. IARC Press. http:\/\/globocan.iarc.fr. 2012"},{"issue":"3","key":"13_CR40","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1525-1438.2007.01056.x","volume":"18","author":"G Ferrandina","year":"2008","unstructured":"Ferrandina G, Bonanno G, Pierelli L, Perillo A, Procoli A, Mariotti A, Corallo M, Martinelli E, Rutella S, Paglia A, Zannoni G, Mancuso S, Scambia G (2008) Expression of CD133-1 and CD133-2 in ovarian cancer. International Journal Gynecological Cancer 18(3):506\u2013514. doi:10.1111\/j.1525-1438.2007.01056.x","journal-title":"International Journal Gynecological Cancer"},{"key":"13_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/1471-2407-9-221","volume":"9","author":"G Ferrandina","year":"2009","unstructured":"Ferrandina G, Martinelli E, Petrillo M, Prisco MG, Zannoni G, Sioletic S, Scambia G (2009) CD133 antigen expression in ovarian cancer. Bmc Cancer 9:221. doi:10.1186\/1471-2407-9-221","journal-title":"Bmc Cancer"},{"issue":"3","key":"13_CR42","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/ijc.23563","volume":"123","author":"H Fiegl","year":"2008","unstructured":"Fiegl H, Windbichler G, Mueller-Holzner E, Goebel G, Lechner M, Jacobs IJ, Widschwendter M (2008) HOXA11 DNA methylation\u2013a novel prognostic biomarker in ovarian cancer. Int J Cancer 123(3):725\u2013729. doi:10.1002\/ijc.23563","journal-title":"Int J Cancer"},{"issue":"1","key":"13_CR43","first-page":"113","volume":"25","author":"MY Fong","year":"2010","unstructured":"Fong MY, Kakar SS (2010) The role of cancer stem cells and the side population in epithelial ovarian cancer. Histology Histopathology 25(1):113\u2013120","journal-title":"Histology Histopathology"},{"issue":"2","key":"13_CR44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4161\/cc.7.2.5207","volume":"7","author":"AM Friel","year":"2008","unstructured":"Friel AM, Sergent PA, Patnaude C, Szotek PP, Oliva E, Scadden DT, Seiden MV, Foster R, Rueda BR (2008) Functional analyses of the cancer stem cell-like properties of human endometrial tumor initiating cells. Cell Cycle 7(2):242\u2013249","journal-title":"Cell Cycle"},{"key":"13_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1477-7827-8-147","volume":"8","author":"AM Friel","year":"2010","unstructured":"Friel AM, Zhang L, Curley MD, Therrien VA, Sergent PA, Belden SE, Borger DR, Mohapatra G, Zukerberg LR, Foster R, Rueda BR (2010) Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells. Reprod Biol Endocrinol 8:147. doi:10.1186\/1477-7827-8-147","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"13_CR46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1757-2215-5-2","volume":"5","author":"MF Gallagher","year":"2012","unstructured":"Gallagher MF, Heffron CC, Laios A, O\u2019Toole SA, Ffrench B, Smyth PC, Flavin RJ, Elbaruni SA, Spillane CD, Martin CM, Sheils OM, O\u2019Leary JJ (2012) Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samples. J Ovarian Res 5(1):2. doi:10.1186\/1757-2215-5-2","journal-title":"J Ovarian Res"},{"issue":"4","key":"13_CR47","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/01913120903086072","volume":"33","author":"Q Gao","year":"2009","unstructured":"Gao Q, Geng L, Kvalheim G, Gaudernack G, Suo Z (2009) Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3. Ultrastruct Pathol 33(4):175\u2013181. doi:10.1080\/01913120903086072","journal-title":"Ultrastruct Pathol"},{"issue":"5","key":"13_CR48","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1479-828X.2004.00290.x","volume":"44","author":"CE Gargett","year":"2004","unstructured":"Gargett CE (2004) Stem cells in gynaecology. Aust N Z J Obstet Gynaecol 44(5):380\u2013386. doi:10.1111\/j.1479-828X.2004.00290.x","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"3","key":"13_CR49","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1479-828X.2006.00582.x","volume":"46","author":"CE Gargett","year":"2006","unstructured":"Gargett CE (2006) Identification and characterisation of human endometrial stem\/progenitor cells. Aust N Z J Obstet Gynaecol 46(3):250\u2013253. doi:10.1111\/j.1479-828X.2006.00582.x","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"3","key":"13_CR50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/157489210791760535","volume":"5","author":"D Giuffrida","year":"2010","unstructured":"Giuffrida D, Rogers IM (2010) Targeting cancer stem cell lines as a new treatment of human cancer. Recent Pat Anticancer Drug Discov 5(3):205\u2013218","journal-title":"Recent Pat Anticancer Drug Discov"},{"issue":"22","key":"13_CR51","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1001\/jama.291.22.2705","volume":"291","author":"BA Goff","year":"2004","unstructured":"Goff BA, Mandel LS, Melancon CH, Muntz HG (2004) Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA 291(22):2705\u20132712. doi:10.1001\/jama.291.22.2705","journal-title":"JAMA"},{"issue":"8","key":"13_CR52","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/ijc.25856","volume":"129","author":"M Gotte","year":"2011","unstructured":"Gotte M, Greve B, Kelsch R, Muller-Uthoff H, Weiss K, Kharabi Masouleh B, Sibrowski W, Kiesel L, Buchweitz O (2011) The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1\/CIP1. Int J Cancer 129(8):2042\u20132049. doi:10.1002\/ijc.25856","journal-title":"Int J Cancer"},{"issue":"3","key":"13_CR53","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/path.2364","volume":"215","author":"M Gotte","year":"2008","unstructured":"Gotte M, Wolf M, Staebler A, Buchweitz O, Kelsch R, Schuring AN, Kiesel L (2008) Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma. J Pathol 215(3):317\u2013329. doi:10.1002\/path.2364","journal-title":"J Pathol"},{"issue":"7381","key":"13_CR54","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature10762","volume":"481","author":"M Greaves","year":"2012","unstructured":"Greaves M, Maley CC (2012) Clonal evolution in cancer. Nature 481(7381):306\u2013313. doi:10.1038\/nature10762","journal-title":"Nature"},{"issue":"18","key":"13_CR55","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.4161\/cbt.8.18.9285","volume":"8","author":"JM Green","year":"2009","unstructured":"Green JM, Alvero AB, Kohen F, Mor G (2009) 7-(O)-Carboxymethyl daidzein conjugated to N-t-Boc-hexylenediamine: a novel compound capable of inducing cell death in epithelial ovarian cancer stem cells. Cancer Biol Ther 8(18):1747\u20131753","journal-title":"Cancer Biol Ther"},{"issue":"7","key":"13_CR56","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/s1470-2045(04)01509-8","volume":"5","author":"C Grommes","year":"2004","unstructured":"Grommes C, Landreth G, Heneka M (2004) Antineoplastic effects of peroxisome proliferatoractivated receptor \u03b3 agonists. Lancet Oncol 5(7):419\u2013429. doi:10.1016\/s1470-2045(04)01509-8","journal-title":"Lancet Oncol"},{"issue":"2","key":"13_CR57","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ajpath.2012.04.008","volume":"181","author":"TT Gu","year":"2012","unstructured":"Gu TT, Liu SY, Zheng PS (2012) Cytoplasmic NANOG-positive stromal cells promote human cervical cancer progression. Am J Pathol 181(2):652\u2013661. doi:10.1016\/j.ajpath.2012.04.008","journal-title":"Am J Pathol"},{"issue":"5","key":"13_CR58","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1007\/s12032-012-0252-6","volume":"29","author":"AK Guddati","year":"2012","unstructured":"Guddati AK (2012) Ovarian cancer stem cells: elusive targets for chemotherapy. Med Oncol 29(5):3400\u20133408. doi:10.1007\/s12032-012-0252-6","journal-title":"Med Oncol"},{"issue":"23","key":"13_CR59","doi-asserted-by":"publisher","first-page":"5759","DOI":"10.1158\/1078-0432.CCR-10-1095","volume":"16","author":"Y Guo","year":"2010","unstructured":"Guo Y, Nemeth J, O\u2019Brien C, Susa M, Liu X, Zhang Z, Choy E, Mankin H, Hornicek F, Duan Z (2010) Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancer. Clin Cancer Res 16(23):5759\u20135769. doi:10.1158\/1078-0432.CCR-10-1095","journal-title":"Clin Cancer Res"},{"issue":"9","key":"13_CR60","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/nm0909-1010","volume":"15","author":"PB Gupta","year":"2009","unstructured":"Gupta PB, Chaffer CL, Weinberg RA (2009) Cancer stem cells: mirage or reality? Nat Med 15(9):1010\u20131012. doi:10.1038\/nm0909-1010","journal-title":"Nat Med"},{"issue":"19","key":"13_CR61","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1016\/j.yexcr.2006.08.030","volume":"312","author":"A Hadnagy","year":"2006","unstructured":"Hadnagy A, Gaboury L, Beaulieu R, Balicki D (2006) SP analysis may be used to identify cancer stem cell populations. Exp Cell Res 312(19):3701\u20133710. doi:10.1016\/j.yexcr.2006.08.030","journal-title":"Exp Cell Res"},{"key":"13_CR62","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1525-1438.2003.13350.x","volume":"13","author":"TC Hamilton","year":"2003","unstructured":"Hamilton TC, Connolly DC, Nikitin AY, Garson K, Vanderhyden BC (2003) Translational research in ovarian cancer: a must. Int J Gynecol Cancer 13:220\u2013230. doi:10.1111\/j.1525-1438.2003.13350.x","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"13_CR63","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674. doi:10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"issue":"Suppl 1","key":"13_CR64","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0020-7292(03)90118-4","volume":"83","author":"AP Heintz","year":"2003","unstructured":"Heintz AP, Odicino F, Maisonneuve P, Beller U, Benedet JL, Creasman WT, Ngan HY, Pecorelli S (2003) Carcinoma of the ovary. Int J Gynaecol Obstet 83(Suppl 1):135\u2013166. doi:10.1016\/S0020-7292(03)90118-4","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"13_CR65","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/Path.4110","volume":"229","author":"M Herfs","year":"2013","unstructured":"Herfs M, Vargas SO, Yamamoto Y, Howitt BE, Nucci MR, Hornick JL, Mckeon FD, Xian W, Crum CP (2013) A novel blueprint for \u2018top down\u2019 differentiation defines the cervical squamocolumnar junction during development, reproductive life, and neoplasia. J Pathol 229(3):460\u2013468. doi:10.1002\/Path.4110","journal-title":"J Pathol"},{"issue":"3","key":"13_CR66","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","volume":"1","author":"PC Hermann","year":"2007","unstructured":"Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1(3):313\u2013323. doi:10.1016\/j.stem.2007.06.002","journal-title":"Cell Stem Cell"},{"issue":"8","key":"13_CR67","first-page":"BR221","volume":"17","author":"J Hu","year":"2011","unstructured":"Hu J, Yuan R (2011) The expression levels of stem cell markers importin13, c-kit, CD146, and telomerase are decreased in endometrial polyps. Med Sci Monit 17(8):BR221\u2013BR227","journal-title":"Med Sci Monit"},{"issue":"21","key":"13_CR68","doi-asserted-by":"publisher","first-page":"8241","DOI":"10.1158\/0008-5472.CAN-08-4808","volume":"69","author":"SA Hubbard","year":"2009","unstructured":"Hubbard SA, Friel AM, Kumar B, Zhang L, Rueda BR, Gargett CE (2009) Evidence for cancer stem cells in human endometrial carcinoma. Cancer Res 69(21):8241\u20138248. doi:10.1158\/0008-5472.CAN-08-4808","journal-title":"Cancer Res"},{"issue":"18","key":"13_CR69","doi-asserted-by":"publisher","first-page":"8699","DOI":"10.1158\/0008-5472.CAN-07-1936","volume":"67","author":"MV Iorio","year":"2007","unstructured":"Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, Menard S, Croce CM (2007) MicroRNA signatures in human ovarian cancer. Cancer Res 67(18):8699\u20138707. doi:10.1158\/0008-5472.CAN-07-1936","journal-title":"Cancer Res"},{"issue":"2","key":"13_CR70","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69\u201390. doi:10.3322\/caac.20107","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"13_CR71","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4161\/epi.23503","volume":"8","author":"K Juarez-Moreno","year":"2013","unstructured":"Juarez-Moreno K, Erices R, Beltran AS, Stolzenburg S, Cuello-Fredes M, Owen GI, Qian H, Blancafort P (2013) Breaking through an epigenetic wall: re-activation of Oct4 by KRAB-containing designer zinc finger transcription factors. Epigenetics 8(2):164\u2013176. doi:10.4161\/epi.23503","journal-title":"Epigenetics"},{"issue":"6","key":"13_CR72","first-page":"2283","volume":"32","author":"K Kato","year":"2012","unstructured":"Kato K (2012) Endometrial cancer stem cells: a new target for cancer therapy. Anticancer Res 32(6):2283\u20132293","journal-title":"Anticancer Res"},{"issue":"2","key":"13_CR73","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.kjms.2011.06.028","volume":"28","author":"K Kato","year":"2012","unstructured":"Kato K (2012) Stem cells in human normal endometrium and endometrial cancer cells: characterization of side population cells. Kaohsiung J Med Sci 28(2):63\u201371. doi:10.1016\/j.kjms.2011.06.028","journal-title":"Kaohsiung J Med Sci"},{"issue":"8","key":"13_CR74","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1158\/1535-7163.MCT-10-1062","volume":"10","author":"K Kato","year":"2011","unstructured":"Kato K, Kuhara A, Yoneda T, Inoue T, Takao T, Ohgami T, Dan L, Kuboyama A, Kusunoki S, Takeda S, Wake N (2011) Sodium butyrate inhibits the self-renewal capacity of endometrial tumor side-population cells by inducing a DNA damage response. Mol Cancer Ther 10(8):1430\u20131439. doi:10.1158\/1535-7163.MCT-10-1062","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"13_CR75","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2353\/ajpath.2010.090056","volume":"176","author":"K Kato","year":"2010","unstructured":"Kato K, Takao T, Kuboyama A, Tanaka Y, Ohgami T, Yamaguchi S, Adachi S, Yoneda T, Ueoka Y, Kato K, Hayashi S, Asanoma K, Wake N (2010) Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage. Am J Pathol 176(1):381\u2013392. doi:10.2353\/ajpath.2010.090056","journal-title":"Am J Pathol"},{"issue":"1","key":"13_CR76","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1757-2215-4-16","volume":"4","author":"ZL Kelly","year":"2011","unstructured":"Kelly ZL, Michael A, Butler-Manuel S, Pandha HS, Morgan RG (2011) HOX genes in ovarian cancer. J Ovarian Res 4(1):16. doi:10.1186\/1757-2215-4-16","journal-title":"J Ovarian Res"},{"issue":"1","key":"13_CR77","first-page":"1","volume":"9","author":"HP Koeffler","year":"2003","unstructured":"Koeffler HP (2003) Peroxisome proliferator-activated receptor gamma and cancers. Clin Cancer Res 9(1):1\u20139","journal-title":"Clin Cancer Res"},{"issue":"2","key":"13_CR78","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.bbrc.2012.09.067","volume":"427","author":"J Koh","year":"2012","unstructured":"Koh J, Lee SB, Park H, Lee HJ, Cho NH, Kim J (2012) Susceptibility of CD24(+) ovarian cancer cells to anti-cancer drugs and natural killer cells. Biochem Biophys Res Commun 427(2):373\u2013378. doi:10.1016\/j.bbrc.2012.09.067","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"13_CR79","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/S0002-9440(10)64398-2","volume":"161","author":"G Kristiansen","year":"2002","unstructured":"Kristiansen G, Denkert C, Schluns K, Dahl E, Pilarsky C, Hauptmann S (2002) CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am J Pathol 161(4):1215\u20131221. doi:10.1016\/S0002-9440(10)64398-2","journal-title":"Am J Pathol"},{"issue":"1","key":"13_CR80","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ijc.25967","volume":"130","author":"I Kryczek","year":"2012","unstructured":"Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S, Banerjee M, Mao Y, Kotarski J, Wicha MS, Liu R, Zou W (2012) Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. Int J Cancer 130(1):29\u201339. doi:10.1002\/ijc.25967","journal-title":"Int J Cancer"},{"issue":"6","key":"13_CR81","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1517\/14712598.2010.482098","volume":"10","author":"JE Kurtz","year":"2010","unstructured":"Kurtz JE, Dufour P (2010) Adecatumumab: an anti-EpCAM monoclonal antibody, from the bench to the bedside. Expert Opin Biol Ther 10(6):951\u2013958. doi:10.1517\/14712598.2010.482098","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"13_CR82","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.canlet.2011.05.015","volume":"308","author":"S Kyo","year":"2011","unstructured":"Kyo S, Maida Y, Inoue M (2011) Stem cells in endometrium and endometrial cancer: accumulating evidence and unresolved questions. Cancer Lett 308(2):123\u2013133. doi:10.1016\/j.canlet.2011.05.015","journal-title":"Cancer Lett"},{"key":"13_CR83","unstructured":"Lacey JV, Sherman ME (2009) Ovarian neoplasia. In: Robboy SJ, Bentley RC, Russell P, Anderson MC, Mutter GL, Prat J (eds) Robboy\u2019s pathology of the female reproductive tract, vol 1, 2nd edn.Churchill Livingstone Elsevier, Oxford. p 601"},{"issue":"12","key":"13_CR84","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1158\/1535-7163.MCT-10-0563","volume":"9","author":"CN Landen Jr","year":"2010","unstructured":"Landen CN Jr, Goodman B, Katre AA, Steg AD, Nick AM, Stone RL, Miller LD, Mejia PV, Jennings NB, Gershenson DM, Bast RC Jr, Coleman RL, Lopez-Berestein G, Sood AK (2010) Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer. Mol Cancer Ther 9(12):3186\u20133199. doi:10.1158\/1535-7163.MCT-10-0563","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"13_CR85","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E (2010) Ovarian cancer development and metastasis. Am J Pathol 177(3):1053\u20131064. doi:10.2353\/ajpath.2010.100105","journal-title":"Am J Pathol"},{"issue":"1","key":"13_CR86","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/carcin\/bgn230","volume":"30","author":"X Liao","year":"2009","unstructured":"Liao X, Siu MK, Au CW, Wong ES, Chan HY, Ip PP, Ngan HY, Cheung AN (2009) Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation. Carcinogenesis 30(1):131\u2013140. doi:10.1093\/carcin\/bgn230","journal-title":"Carcinogenesis"},{"issue":"3","key":"13_CR87","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1210\/en.2007-1001","volume":"149","author":"UD Lichtenauer","year":"2008","unstructured":"Lichtenauer UD, Shapiro I, Geiger K, Quinkler M, Fassnacht M, Nitschke R, Ruckauer KD, Beuschlein F (2008) Side population does not define stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI h295R. Endocrinology 149(3):1314\u20131322. doi:10.1210\/en.2007-1001","journal-title":"Endocrinology"},{"issue":"8","key":"13_CR88","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1134\/S0006297912080159","volume":"77","author":"D Liu","year":"2012","unstructured":"Liu D, Zhou P, Zhang L, Gong W, Huang G, Zheng Y, He F (2012) HDAC1\/DNMT3A-containing complex is associated with suppression of Oct4 in cervical cancer cells. Biochemistry Biokhimiia 77(8):934\u2013940. doi:10.1134\/S0006297912080159","journal-title":"Biochemistry Biokhimiia"},{"key":"13_CR89","doi-asserted-by":"publisher","first-page":"232","DOI":"10.2174\/1874357901206010232","volume":"6","author":"J Lopez","year":"2012","unstructured":"Lopez J, Ruiz G, Organista-Nava J, Gariglio P, Garcia-Carranca A (2012) Human papillomavirus infections and cancer stem cells of tumors from the uterine cervix. Open Virol J 6:232\u2013240. doi:10.2174\/1874357901206010232","journal-title":"Open Virol J"},{"issue":"6","key":"13_CR90","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.tiv.2010.07.017","volume":"24","author":"B Lu","year":"2010","unstructured":"Lu B, Hu M, Liu K, Peng J (2010) Cytotoxicity of berberine on human cervical carcinoma HeLa cells through mitochondria, death receptor and MAPK pathways, and in-silico drug-target prediction. Toxicol In Vitro 24(6):1482\u20131490. doi:10.1016\/j.tiv.2010.07.017","journal-title":"Toxicol In Vitro"},{"issue":"9","key":"13_CR91","first-page":"1127","volume":"26","author":"X Lu","year":"2011","unstructured":"Lu X, Lin F, Fang H, Yang X, Qin L (2011) Expression of a putative stem cell marker Musashi-1 in endometrium. Histol Histopathol 26(9):1127\u20131133","journal-title":"Histol Histopathol"},{"issue":"2","key":"13_CR92","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.yexmp.2011.06.005","volume":"91","author":"L Luo","year":"2011","unstructured":"Luo L, Zeng J, Liang B, Zhao Z, Sun L, Cao D, Yang J, Shen K (2011) Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome. Exp Mol Pathol 91(2):596\u2013602. doi:10.1016\/j.yexmp.2011.06.005","journal-title":"Exp Mol Pathol"},{"issue":"9","key":"13_CR93","first-page":"1121","volume":"27","author":"VC Mak","year":"2012","unstructured":"Mak VC, Siu MK, Wong OG, Chan KK, Ngan HY, Cheung AN (2012) Dysregulated stemness-related genes in gynecological malignancies. Histol Histopathol 27(9):1121\u20131130","journal-title":"Histol Histopathol"},{"issue":"8","key":"13_CR94","doi-asserted-by":"publisher","first-page":"784","DOI":"10.2174\/156652408786733667","volume":"8","author":"R Marhaba","year":"2008","unstructured":"Marhaba R, Klingbeil P, Nuebel T, Nazarenko I, Buechler MW, Zoeller M (2008) CD44 and EpCAM: cancer-initiating cell markers. Curr Mol Med 8(8):784\u2013804. doi:10.2174\/156652408786733667","journal-title":"Curr Mol Med"},{"issue":"4","key":"13_CR95","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/jcb.22185","volume":"107","author":"PA Marks","year":"2009","unstructured":"Marks PA, Xu WS (2009) Histone deacetylase inhibitors: potential in cancer therapy. J Cell Biochem 107(4):600\u2013608. doi:10.1002\/jcb.22185","journal-title":"J Cell Biochem"},{"issue":"5","key":"13_CR96","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.mehy.2009.11.029","volume":"74","author":"L Massuger","year":"2010","unstructured":"Massuger L, Roelofsen T, Ham M, Bulten J (2010) The origin of serous ovarian cancer may be found in the uterus: a novel hypothesis. Med Hypotheses 74(5):859\u2013861. doi:10.1016\/j.mehy.2009.11.029","journal-title":"Med Hypotheses"},{"issue":"4","key":"13_CR97","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/cncr.23605","volume":"113","author":"D Matei","year":"2008","unstructured":"Matei D, Emerson RE, Schilder J, Menning N, Baldridge LA, Johnson CS, Breen T, McClean J, Stephens D, Whalen C, Sutton G (2008) Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trial. Cancer 113(4):723\u2013732. doi:10.1002\/cncr.23605","journal-title":"Cancer"},{"key":"13_CR98","doi-asserted-by":"publisher","DOI":"10.3109\/15513815.2012.701266","author":"M Mehrazma","year":"2012","unstructured":"Mehrazma M, Madjd Z, Kalantari E, Panahi M, Hendi A, Shariftabrizi A (2012) Expression of stem cell markers, CD133 and CD44, in pediatric solid tumors: a study using tissue microarray. Fetal Pediatr Pathol. doi:10.3109\/15513815.2012.701266","journal-title":"Fetal Pediatr Pathol"},{"issue":"8","key":"13_CR99","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s10585-012-9482-4","volume":"29","author":"E Meng","year":"2012","unstructured":"Meng E, Long B, Sullivan P, McClellan S, Finan MA, Reed E, Shevde L, Rocconi RP (2012) CD44+\/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival. Clin Exp Metastasis 29(8):939\u2013948. doi:10.1007\/s10585-012-9482-4","journal-title":"Clin Exp Metastasis"},{"issue":"2","key":"13_CR100","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/gcc.20628","volume":"48","author":"F Micci","year":"2009","unstructured":"Micci F, Weimer J, Haugom L, Skotheim RI, Grunewald R, Abeler VM, Silins I, Lothe RA, Trope CG, Arnold N, Heim S (2009) Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement map. Genes Chromosomes Cancer 48(2):184\u2013193. doi:10.1002\/gcc.20628","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"13_CR101","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12015-008-9008-2","volume":"4","author":"M Mimeault","year":"2008","unstructured":"Mimeault M, Batra SK (2008) Recent progress on tissue-resident adult stem cell biology and their therapeutic implications. Stem Cell Rev 4(1):27\u201349. doi:10.1007\/s12015-008-9008-2","journal-title":"Stem Cell Rev"},{"issue":"1","key":"13_CR102","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1757-2215-5-28","volume":"5","author":"KJ Min","year":"2012","unstructured":"Min KJ, So KA, Ouh YT, Hong JH, Lee JK (2012) The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers. J Ovarian Res 5(1):28. doi:10.1186\/1757-2215-5-28","journal-title":"J Ovarian Res"},{"issue":"8","key":"13_CR103","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4161\/cbt.11.8.14967","volume":"11","author":"G Mor","year":"2011","unstructured":"Mor G, Yin G, Chefetz I, Yang Y, Alvero A (2011) Ovarian cancer stem cells and inflammation. Cancer Biol Ther 11(8):708\u2013713","journal-title":"Cancer Biol Ther"},{"issue":"12","key":"13_CR104","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00432-008-0408-0","volume":"134","author":"C Mundhenke","year":"2008","unstructured":"Mundhenke C, Weigel MT, Sturner KH, Roesel F, Meinhold-Heerlein I, Bauerschlag DO, Schem C, Hilpert F, Jonat W, Maass N (2008) Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects. J Cancer Res Clin Oncol 134(12):1397\u20131405. doi:10.1007\/s00432-008-0408-0","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"13_CR105","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/153537020422900613","volume":"229","author":"WJ Murdoch","year":"2004","unstructured":"Murdoch WJ, Martinchick JF (2004) Oxidative damage to DNA of ovarian surface epithelial cells affected by ovulation: carcinogenic implication and chemoprevention. Exp Biol Med 229(6):546\u2013552","journal-title":"Exp Biol Med"},{"issue":"6","key":"13_CR106","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1530\/reprod\/123.6.743","volume":"123","author":"WJ Murdoch","year":"2002","unstructured":"Murdoch WJ, McDonnel AC (2002) Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction 123(6):743\u2013750. doi:10.1530\/reprod\/123.6.743","journal-title":"Reproduction"},{"issue":"3","key":"13_CR107","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ygyno.2006.09.021","volume":"104","author":"A Obermair","year":"2007","unstructured":"Obermair A, Fuller A, Lopez-Varela E, van Gorp T, Vergote I, Eaton L, Fowler J, Quinn M, Hammond I, Marsden D, Proietto A, Carter J, Davy M, Tripcony L, Abu-Rustum N (2007) A new prognostic model for FIGO stage 1 epithelial ovarian cancer. Gynecol Oncol 104(3):607\u2013611. doi:10.1016\/j.ygyno.2006.09.021","journal-title":"Gynecol Oncol"},{"issue":"2","key":"13_CR108","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/ng1972","volume":"39","author":"JE Ohm","year":"2007","unstructured":"Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, Mohammad HP, Chen W, Daniel VC, Yu W, Berman DM, Jenuwein T, Pruitt K, Sharkis SJ, Watkins DN, Herman JG, Baylin SB (2007) A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 39(2):237\u2013242. doi:10.1038\/ng1972","journal-title":"Nat Genet"},{"issue":"2","key":"13_CR109","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1158\/0008-5472.CAN-03-2404","volume":"64","author":"AW Opipari Jr","year":"2004","unstructured":"Opipari AW Jr, Tan L, Boitano AE, Sorenson DR, Aurora A, Liu JR (2004) Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res 64(2):696\u2013703","journal-title":"Cancer Res"},{"issue":"7","key":"13_CR110","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.ejca.2010.02.024","volume":"46","author":"V Orian-Rousseau","year":"2010","unstructured":"Orian-Rousseau V (2010) CD44, a therapeutic target for metastasising tumours. Eur J Cancer 46(7):1271\u20131277. doi:10.1016\/j.ejca.2010.02.024","journal-title":"Eur J Cancer"},{"issue":"3","key":"13_CR111","first-page":"260","volume":"1","author":"Y Pan","year":"2008","unstructured":"Pan Y, Huang X (2008) Epithelial ovarian cancer stem cells-a review. Int J Clin Exp Med 1(3):260\u2013266","journal-title":"Int J Clin Exp Med"},{"issue":"14","key":"13_CR112","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1158\/0008-5472.CAN-05-0592","volume":"65","author":"L Patrawala","year":"2005","unstructured":"Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG (2005) Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 65(14):6207\u20136219. doi:10.1158\/0008-5472.CAN-05-0592","journal-title":"Cancer Res"},{"issue":"1","key":"13_CR113","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1757-2215-5-22","volume":"5","author":"C Peracchio","year":"2012","unstructured":"Peracchio C, Alabiso O, Valente G, Isidoro C (2012) Involvement of autophagy in ovarian cancer: a working hypothesis. J Ovarian Res 5(1):22. doi:10.1186\/1757-2215-5-22","journal-title":"J Ovarian Res"},{"issue":"4","key":"13_CR114","first-page":"163","volume":"1","author":"PV Phuc","year":"2010","unstructured":"Phuc PV, Khuong TTT, Dong LV, Kiet TD, Giang TT, Ngoc PK (2010) Isolation and characterization of breast cancer stem cells from malignant tumours in Vietnamese women. J Ovarian Res 1(4):163\u2013169","journal-title":"J Ovarian Res"},{"issue":"1","key":"13_CR115","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1757-2215-1-4","volume":"1","author":"MP Ponnusamy","year":"2008","unstructured":"Ponnusamy MP, Batra SK (2008) Ovarian cancer: emerging concept on cancer stem cells. J Ovarian Res 1(1):4. doi:10.1186\/1757-2215-1-4","journal-title":"J Ovarian Res"},{"issue":"1","key":"13_CR116","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1757-2215-4-7","volume":"4","author":"MP Ponnusamy","year":"2011","unstructured":"Ponnusamy MP, Seshacharyulu P, Vaz A, Dey P, Batra SK (2011) MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells. J Ovarian Res 4(1):7. doi:10.1186\/1757-2215-4-7","journal-title":"J Ovarian Res"},{"issue":"3","key":"13_CR117","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1073\/pnas.0610117104","volume":"104","author":"ME Prince","year":"2007","unstructured":"Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 104(3):973\u2013978. doi:10.1073\/pnas.0610117104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"13_CR118","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3892\/ijo.2011.1093","volume":"39","author":"A Ray","year":"2011","unstructured":"Ray A, Meng E, Reed E, Shevde LA, Rocconi RP (2011) Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells. Int J Oncol 39(4):797\u2013804. doi:10.3892\/ijo.2011.1093","journal-title":"Int J Oncol"},{"issue":"3","key":"13_CR119","doi-asserted-by":"publisher","first-page":"413","DOI":"10.4161\/mabs.19931","volume":"4","author":"JM Reichert","year":"2012","unstructured":"Reichert JM (2012) Marketed therapeutic antibodies compendium. MAbs 4(3):413\u2013415. doi:10.4161\/mabs.19931","journal-title":"MAbs"},{"issue":"7123","key":"13_CR120","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature05384","volume":"445","author":"L Ricci-Vitiani","year":"2007","unstructured":"Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445(7123):111\u2013115. doi:10.1038\/nature05384","journal-title":"Nature"},{"key":"13_CR121","unstructured":"Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Horner MJ, Howlader N, Eisner MP, Reichman M, Edwards BK (2007) SEER cancer statistics review, 1975\u20132004. National Cancer Institute. Bethesda, MD., p 103. http:\/\/seer.cancer.gov\/archive\/csr\/1975_2004\/results_merged\/sect_01_overview.pdf"},{"issue":"9","key":"13_CR122","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.0001-6349.2004.00550.x","volume":"83","author":"T Riman","year":"2004","unstructured":"Riman T, Nilsson S, Persson IR (2004) Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand 83(9):783\u2013795. doi:10.1111\/j.0001-6349.2004.00550.x","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"13_CR123","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s12015-011-9253-7","volume":"7","author":"A Ruiz-Vela","year":"2011","unstructured":"Ruiz-Vela A, Aguilar-Gallardo C, Martinez-Arroyo AM, Soriano-Navarro M, Ruiz V, Simon C (2011) Specific unsaturated fatty acids enforce the transdifferentiation of human cancer cells toward adipocyte-like cells. Stem Cell Rev 7(4):898\u2013909. doi:10.1007\/s12015-011-9253-7","journal-title":"Stem Cell Rev"},{"issue":"22","key":"13_CR124","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1200\/jco.2004.12.043","volume":"22","author":"P Sabbatini","year":"2004","unstructured":"Sabbatini P, Aghajanian C, Dizon D, Anderson S, Dupont J, Brown JV, Peters WA, Jacobs A, Mehdi A, Rivkin S, Eisenfeld AJ, Spriggs D (2004) Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma. J Clin Oncol 22(22):4523\u20134531. doi:10.1200\/jco.2004.12.043","journal-title":"J Clin Oncol"},{"issue":"1","key":"13_CR125","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1757-2215-5-37","volume":"5","author":"C Samardzija","year":"2012","unstructured":"Samardzija C, Quinn M, Findlay JK, Ahmed N (2012) Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary. J Ovarian Res 5(1):37. doi:10.1186\/1757-2215-5-37","journal-title":"J Ovarian Res"},{"issue":"1","key":"13_CR126","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1172\/JCI41495","volume":"121","author":"JE Sarry","year":"2011","unstructured":"Sarry JE, Murphy K, Perry R, Sanchez PV, Secreto A, Keefer C, Swider CR, Strzelecki AC, Cavelier C, Recher C, Mansat-De Mas V, Delabesse E, Danet-Desnoyers G, Carroll M (2011) Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD\/SCID\/IL2Rgammac-deficient mice. J Clin Invest 121(1):384\u2013395. doi:10.1172\/JCI41495","journal-title":"J Clin Invest"},{"issue":"2","key":"13_CR127","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3892\/ijo.2012.1473","volume":"41","author":"A Sato","year":"2012","unstructured":"Sato A, Ishiwata T, Matsuda Y, Yamamoto T, Asakura H, Takeshita T, Naito Z (2012) Expression and role of nestin in human cervical intraepithelial neoplasia and cervical cancer. Int J Oncol 41(2):441\u2013448. doi:10.3892\/ijo.2012.1473","journal-title":"Int J Oncol"},{"issue":"1","key":"13_CR128","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1755-148X.2007.00427.x","volume":"21","author":"T Schatton","year":"2008","unstructured":"Schatton T, Frank MH (2008) Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res 21(1):39\u201355. doi:10.1111\/j.1755-148X.2007.00427.x","journal-title":"Pigment Cell Melanoma Res"},{"key":"13_CR129","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/978-1-61779-612-8_15","volume":"863","author":"LM Seeber","year":"2012","unstructured":"Seeber LM, van Diest PJ (2012) Epigenetics in ovarian cancer. Methods Mol Biol 863:253\u2013269. doi:10.1007\/978-1-61779-612-8_15","journal-title":"Methods Mol Biol"},{"key":"13_CR130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.7150\/jca.2.309","volume":"2","author":"D Seimetz","year":"2011","unstructured":"Seimetz D (2011) Novel monoclonal antibodies for cancer treatment: the trifunctional antibody catumaxomab (removab). J Cancer 2:309\u2013316","journal-title":"J Cancer"},{"issue":"1","key":"13_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2004.04.007","volume":"51","author":"S Sell","year":"2004","unstructured":"Sell S (2004) Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 51(1):1\u201328. doi:10.1016\/j.critrevonc.2004.04.007","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"13_CR132","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3322\/caac.21153","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A (2012) Cancer statistics for Hispanics\/Latinos, 2012. CA Cancer J Clin 62(5):283\u2013298. doi:10.3322\/caac.21153","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"13_CR133","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1158\/0008-5472.CAN-10-3175","volume":"71","author":"IA Silva","year":"2011","unstructured":"Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds RK, Wicha MS, Buckanovich RJ (2011) Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res 71(11):3991\u20134001. doi:10.1158\/0008-5472.CAN-10-3175","journal-title":"Cancer Res"},{"issue":"21","key":"13_CR134","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.1158\/1078-0432.CCR-12-0662","volume":"18","author":"BM Slomovitz","year":"2012","unstructured":"Slomovitz BM, Coleman RL (2012) The PI3K\/AKT\/mTOR pathway as a therapeutic target in endometrial cancer. Clin Cancer Res 18(21):5856\u20135864. doi:10.1158\/1078-0432.CCR-12-0662","journal-title":"Clin Cancer Res"},{"issue":"1","key":"13_CR135","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/sj.bjc.6604437","volume":"99","author":"LM Smith","year":"2008","unstructured":"Smith LM, Nesterova A, Ryan MC, Duniho S, Jonas M, Anderson M, Zabinski RF, Sutherland MK, Gerber HP, Van Orden KL, Moore PA, Ruben SM, Carter PJ (2008) CD133\/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer 99(1):100\u2013109. doi:10.1038\/sj.bjc.6604437","journal-title":"Br J Cancer"},{"issue":"10","key":"13_CR136","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/sj.leu.2401150","volume":"12","author":"SL Soignet","year":"1998","unstructured":"Soignet SL, Benedetti F, Fleischauer A, Parker BA, Truglia JA, Ra Crisp M, Warrell RP Jr (1998) Clinical study of 9-cis retinoic acid (LGD1057) in acute promyelocytic leukemia. Leukemia 12(10):1518\u20131521","journal-title":"Leukemia"},{"issue":"6","key":"13_CR137","first-page":"435","volume":"52","author":"A Soltysova","year":"2005","unstructured":"Soltysova A, Altanerova V, Altaner C (2005) Cancer stem cells. Neoplasma 52(6):435\u2013440","journal-title":"Neoplasma"},{"issue":"2","key":"13_CR138","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ygyno.2006.03.035","volume":"103","author":"G Spizzo","year":"2006","unstructured":"Spizzo G, Went P, Dirnhofer S, Obrist P, Moch H, Baeuerle PA, Mueller-Holzner E, Marth C, Gastl G, Zeimet AG (2006) Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer. Gynecol Oncol 103(2):483\u2013488. doi:10.1016\/j.ygyno.2006.03.035","journal-title":"Gynecol Oncol"},{"issue":"3","key":"13_CR139","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1158\/1078-0432.CCR-11-2188","volume":"18","author":"AD Steg","year":"2012","unstructured":"Steg AD, Bevis KS, Katre AA, Ziebarth A, Dobbin ZC, Alvarez RD, Zhang K, Conner M, Landen CN (2012) Stem cell pathways contribute to clinical chemoresistance in ovarian cancer. Clin Cancer Res 18(3):869\u2013881. doi:10.1158\/1078-0432.CCR-11-2188","journal-title":"Clin Cancer Res"},{"issue":"1","key":"13_CR140","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/onc.2012.29","volume":"32","author":"PH Su","year":"2013","unstructured":"Su PH, Lin YW, Huang RL, Liao YP, Lee HY, Wang HC, Chao TK, Chen CK, Chan MW, Chu TY, Yu MH, Lai HC (2013) Epigenetic silencing of PTPRR activates MAPK signaling, promotes metastasis and serves as a biomarker of invasive cervical cancer. Oncogene 32(1):15\u201326. doi:10.1038\/onc.2012.29","journal-title":"Oncogene"},{"issue":"30","key":"13_CR141","doi-asserted-by":"publisher","first-page":"11154","DOI":"10.1073\/pnas.0603672103","volume":"103","author":"PP Szotek","year":"2006","unstructured":"Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT, Donahoe PK (2006) Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci U S A 103(30):11154\u201311159. doi:10.1073\/pnas.0603672103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"13_CR142","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/stem.30","volume":"27","author":"S Takaishi","year":"2009","unstructured":"Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y, Wang TC (2009) Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27(5):1006\u20131020. doi:10.1002\/stem.30","journal-title":"Stem Cells"},{"issue":"1","key":"13_CR143","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1757-2215-4-10","volume":"4","author":"BL Theriault","year":"2011","unstructured":"Theriault BL, Shepherd TG (2011) On the path to translation: highlights from the 2010 Canadian Conference on Ovarian Cancer Research. J Ovarian Res 4(1):10. doi:10.1186\/1757-2215-4-10","journal-title":"J Ovarian Res"},{"issue":"1","key":"13_CR144","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1096\/fj.12-218222","volume":"27","author":"V Tirino","year":"2013","unstructured":"Tirino V, Desiderio V, Paino F, De Rosa A, Papaccio F, La Noce M, Laino L, De Francesco F, Papaccio G (2013) Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB J 27(1):13\u201324. doi:10.1096\/fj.12-218222","journal-title":"FASEB J"},{"issue":"5","key":"13_CR145","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1054\/bjoc.2000.1596","volume":"84","author":"L Titus-Ernstoff","year":"2001","unstructured":"Titus-Ernstoff L, Perez K, Cramer DW, Harlow BL, Baron JA, Greenberg ER (2001) Menstrual and reproductive factors in relation to ovarian cancer risk. Br J Cancer 84(5):714\u2013721. doi:10.1054\/bjoc.2000.1596","journal-title":"Br J Cancer"},{"issue":"1","key":"13_CR146","doi-asserted-by":"publisher","first-page":"e29079","DOI":"10.1371\/journal.pone.0029079","volume":"7","author":"V Vathipadiekal","year":"2012","unstructured":"Vathipadiekal V, Saxena D, Mok SC, Hauschka PV, Ozbun L, Birrer MJ (2012) Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer. PLoS One 7(1):e29079. doi:10.1371\/journal.pone.0029079","journal-title":"PLoS One"},{"issue":"5","key":"13_CR147","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cell.2008.02.019","volume":"132","author":"A Ventura","year":"2008","unstructured":"Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, Jaenisch R, Sharp PA, Jacks T (2008) Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132(5):875\u2013886. doi:10.1016\/j.cell.2008.02.019","journal-title":"Cell"},{"issue":"1","key":"13_CR148","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0002-9378(93)90129-7","volume":"169","author":"IB Vergote","year":"1993","unstructured":"Vergote IB, Kaern J, Abeler VM, Pettersen EO, De Vos LN, Trope CG (1993) Analysis of prognostic factors in stage I epithelial ovarian carcinoma: importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse. Am J Obstet Gynecol 169(1):40\u201352","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"13_CR149","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1593\/neo.06433","volume":"8","author":"S Vignati","year":"2006","unstructured":"Vignati S, Albertini V, Rinaldi A, Kwee I, Riva C, Oldrini R, Capella C, Bertoni F, Carbone GM, Catapano CV (2006) Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells. Neoplasia 8(10):851\u2013861. doi:10.1593\/neo.06433","journal-title":"Neoplasia"},{"issue":"10","key":"13_CR150","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrc2499","volume":"8","author":"JE Visvader","year":"2008","unstructured":"Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8(10):755\u2013768. doi:10.1038\/nrc2499","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"13_CR151","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","volume":"10","author":"JE Visvader","year":"2012","unstructured":"Visvader JE, Lindeman GJ (2012) Cancer stem cells: current status and evolving complexities. Cell Stem Cell 10(6):717\u2013728. doi:10.1016\/j.stem.2012.05.007","journal-title":"Cell Stem Cell"},{"issue":"1","key":"13_CR152","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(Sici)1096-9896(199909)189:1<12::Aid-Path431>3.0.Co;2-F","volume":"189","author":"JMM Walboomers","year":"1999","unstructured":"Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12\u201319. doi:10.1002\/(Sici)1096-9896(199909)189:1<12::Aid-Path431>3.0.Co;2-F","journal-title":"J Pathol"},{"issue":"1","key":"13_CR153","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/1479-5876-10-207","volume":"10","author":"H Wang","year":"2012","unstructured":"Wang H, Jin P, Sabatino M, Ren J, Civini S, Bogin V, Ichim TE, Stroncek DF (2012) Comparison of endometrial regenerative cells and bone marrow stromal cells. J Transl Med 10(1):207. doi:10.1186\/1479-5876-10-207","journal-title":"J Transl Med"},{"issue":"7","key":"13_CR154","doi-asserted-by":"crossref","first-page":"674","DOI":"10.18632\/oncotarget.201","volume":"1","author":"Y Wang","year":"2010","unstructured":"Wang Y, van der Zee M, Fodde R, Blok LJ (2010) Wnt\/Beta-catenin and sex hormone signaling in endometrial homeostasis and cancer. Oncotarget 1(7):674\u2013684","journal-title":"Oncotarget"},{"issue":"3","key":"13_CR155","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.ajpath.2011.11.015","volume":"180","author":"YC Wang","year":"2012","unstructured":"Wang YC, Yo YT, Lee HY, Liao YP, Chao TK, Su PH, Lai HC (2012) ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome. Am J Pathol 180(3):1159\u20131169. doi:10.1016\/j.ajpath.2011.11.015","journal-title":"Am J Pathol"},{"issue":"4","key":"13_CR156","doi-asserted-by":"publisher","first-page":"e5137","DOI":"10.1371\/journal.pone.0005137","volume":"4","author":"SN Wingo","year":"2009","unstructured":"Wingo SN, Gallardo TD, Akbay EA, Liang MC, Contreras CM, Boren T, Shimamura T, Miller DS, Sharpless NE, Bardeesy N, Kwiatkowski DJ, Schorge JO, Wong KK, Castrillon DH (2009) Somatic LKB1 mutations promote cervical cancer progression. PLoS One 4(4):e5137. doi:10.1371\/journal.pone.0005137","journal-title":"PLoS One"},{"issue":"8","key":"13_CR157","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/ncb1616","volume":"9","author":"K Wolf","year":"2007","unstructured":"Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, Stack MS, Friedl P (2007) Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 9(8):893\u2013904. doi:10.1038\/ncb1616","journal-title":"Nat Cell Biol"},{"key":"13_CR158","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1471-2407-8-108","volume":"8","author":"F Ye","year":"2008","unstructured":"Ye F, Zhou C, Cheng Q, Shen J, Chen H (2008) Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells. BMC Cancer 8:108. doi:10.1186\/1471-2407-8-108","journal-title":"BMC Cancer"},{"issue":"2","key":"13_CR159","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/1568009611313020009","volume":"13","author":"GP Yee","year":"2013","unstructured":"Yee GP, de Souza P, Khachigian LM (2013) Current and potential treatments for cervical cancer. Curr Cancer Drug Targets 13(2):205\u2013220","journal-title":"Curr Cancer Drug Targets"},{"issue":"6","key":"13_CR160","doi-asserted-by":"publisher","first-page":"457","DOI":"10.4149\/neo_2011_06_457","volume":"58","author":"L Zavesky","year":"2011","unstructured":"Zavesky L, Jancarkova N, Kohoutova M (2011) Ovarian cancer: origin and factors involved in carcinogenesis with potential use in diagnosis, treatment and prognosis of the disease. Neoplasma 58(6):457\u2013468. doi:10.4149\/neo_2011_06_457","journal-title":"Neoplasma"},{"issue":"6","key":"13_CR161","doi-asserted-by":"crossref","first-page":"CR361","DOI":"10.12659\/MSM.882879","volume":"18","author":"B Zeng","year":"2012","unstructured":"Zeng B, Hu J, Yuan R, Hu L, Zhong L, Kang K (2012) Increased expression of importin13 in endometriosis and endometrial carcinoma. Med Sci Monit 18(6):CR361\u2013CR367","journal-title":"Med Sci Monit"},{"issue":"19","key":"13_CR162","doi-asserted-by":"publisher","first-page":"7004","DOI":"10.1073\/pnas.0801615105","volume":"105","author":"L Zhang","year":"2008","unstructured":"Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, Liu CG, Giannakakis A, Alexiou P, Hasegawa K, Johnstone CN, Megraw MS, Adams S, Lassus H, Huang J, Kaur S, Liang S, Sethupathy P, Leminen A, Simossis VA, Sandaltzopoulos R, Naomoto Y, Katsaros D, Gimotty PA, DeMichele A, Huang Q, Butzow R, Rustgi AK, Weber BL, Birrer MJ, Hatzigeorgiou AG, Croce CM, Coukos G (2008) Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci U S A 105(19):7004\u20137009. doi:10.1073\/pnas.0801615105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"13_CR163","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","volume":"68","author":"S Zhang","year":"2008","unstructured":"Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP (2008) Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68(11):4311\u20134320. doi:10.1158\/0008-5472.CAN-08-0364","journal-title":"Cancer Res"},{"key":"13_CR164","unstructured":"American Cancer Society (2013) Cancer facts and figures 2013. Corporate Center: American Cancer Society Inc. NW, Atlanta, GA, p 62 (online. http:\/\/www.cancer.org\/acs\/groups\/content\/@epidemiologysurveilance\/documents\/document\/acspc-036845.pdf"},{"key":"13_CR165","unstructured":"World Health Organization (2010) HPV and cervical cancer (HPV Information Center). Human papillomavirus and related cancers in the world. Summary Report 2010. http:\/\/www.who.int\/hpvcentre\/en"}],"container-title":["Stem Cells in Cancer: Should We Believe or Not?"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-017-8754-3_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T01:20:47Z","timestamp":1676856047000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-017-8754-3_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9789401787536","9789401787543"],"references-count":165,"URL":"https:\/\/doi.org\/10.1007\/978-94-017-8754-3_13","relation":{},"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"21 March 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}